Enliven Therapeutics (ELVN) AI Analysis
ELVN$47.70-0.60 -1.25%
Market cap$3.51BEnterprise value$3.62BRevenue (TTM)$0Market position—
Score
68
Bullish
Value
58
Quality
47
Growth
100
Enliven Therapeutics is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 68/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~60% upside.